Description
OPTION YEAR 3 HEVYLITE KAPP LAMBDA TEST KITS FOR SPAPLUS ANALYZER
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-04-26+$160,000= $160,000
- Mod P000012020-01-29+$75,000= $235,000
- Mod P000022021-01-28-$454= $234,546
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-04-26 | +$160,000 | $160,000 | OPTION YEAR 3 HEVYLITE KAPP LAMBDA TEST KITS FOR SPAPLUS ANALYZER |
| Mod P00001· FUNDING ONLY ACTION | 2020-01-29 | +$75,000 | $235,000 | OPTION YEAR 3 HEVYLITE KAPP LAMBDA TEST KITS FOR SPAPLUS ANALYZER |
| Mod P00002· FUNDING ONLY ACTION | 2021-01-28 | −$454 | $234,546 | OPTION YEAR 3 HEVYLITE KAPP LAMBDA TEST KITS FOR SPAPLUS ANALYZER |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI ETZEQNG96NN5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026N0395 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $69,423 | FY2026 |
| 36C24826N0254 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $74,121 | FY2026 |
| 36C25026F0294 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $183,301 | FY2026 |
| 36C24126N0140 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $276,000 | FY2026 |
| 36C24126A0010 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C26226N0172 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $428,607 | FY2026 |
Other recipients under 6550 from 241-NETWORK CONTRACT OFFICE 01 (36C241) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24126N0852 | ORTHO-CLINICAL DIAGNOSTICS, INC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $2,023 | FY2026 |
| 36C24126N0884 | ORTHO-CLINICAL DIAGNOSTICS, INC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $23,706 | FY2026 |
| 36C24126N0887 | ORTHO-CLINICAL DIAGNOSTICS, INC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $2,003 | FY2026 |
| 36C24126N0802 | GOVERNMENT SCIENTIFIC SOURCE INC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $6,847 | FY2026 |
| 36C24126N0855 | GOVERNMENT SCIENTIFIC SOURCE INC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $1,989 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24119N0662_3600_VA24115D0135_3600 · retrieved 2026-09-26.